New generation of dendritic cell vaccines

References

• Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001; 2:1144 - 50; http://dx.doi.org/10.1038/ni736; PMID: 11713464
   PubMed Web of Science ®Google Scholar
• Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O’Keeffe M. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol 2001; 166:5448 - 55; PMID: 11313382
   PubMed Web of Science ®Google Scholar
• Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23:275 - 306; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115633; PMID: 15771572
   PubMed Web of Science ®Google Scholar
• Heath WR, Carbone FR. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009; 10:1237 - 44; http://dx.doi.org/10.1038/ni.1822; PMID: 19915624
   PubMed Web of Science ®Google Scholar
• Shortman K, Heath WR. The CD8+ dendritic cell subset. Immunol Rev 2010; 234:18 - 31; http://dx.doi.org/10.1111/j.0105-2896.2009.00870.x; PMID: 20193009
   PubMed Web of Science ®Google Scholar
• Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25:153 - 62; http://dx.doi.org/10.1016/j.immuni.2006.04.017; PMID: 16860764
   PubMed Web of Science ®Google Scholar
• Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005; 22:19 - 29; http://dx.doi.org/10.1016/j.immuni.2004.11.013; PMID: 15664156
   PubMed Web of Science ®Google Scholar
• Wilson NS, Young LJ, Kupresanin F, Naik SH, Vremec D, Heath WR, et al. Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling. Immunol Cell Biol 2008; 86:200 - 5; http://dx.doi.org/10.1038/sj.icb.7100125; PMID: 18026177
   PubMed Web of Science ®Google Scholar
• Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, Caminschi I, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 2009; 10:488 - 95; http://dx.doi.org/10.1038/ni.1724; PMID: 19349986
   PubMed Web of Science ®Google Scholar
• Caminschi I, Maraskovsky E, Heath WR. Targeting Dendritic Cells in vivo for Cancer Therapy. Front Immunol 2012; 3:13; http://dx.doi.org/10.3389/fimmu.2012.00013; PMID: 22566899
   PubMed Web of Science ®Google Scholar
• Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, de Bovis B, et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 2010; 207:S1-6 189 - 206; http://dx.doi.org/10.1084/jem.20091964; PMID: 20038600
   PubMed Web of Science ®Google Scholar
• Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007; 7:19 - 30; http://dx.doi.org/10.1038/nri1996; PMID: 17170756
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 2007; 179:7577 - 84; PMID: 18025203
   PubMed Web of Science ®Google Scholar
• Robbins SH, Walzer T, Dembélé D, Thibault C, Defays A, Bessou G, et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol 2008; 9:R17; http://dx.doi.org/10.1186/gb-2008-9-1-r17; PMID: 18218067
   PubMed Web of Science ®Google Scholar
• Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008; 322:1097 - 100; http://dx.doi.org/10.1126/science.1164206; PMID: 19008445
   PubMed Web of Science ®Google Scholar
• Mashayekhi M, Sandau MM, Dunay IR, Frickel EM, Khan A, Goldszmid RS, et al. CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 2011; 35:249 - 59; http://dx.doi.org/10.1016/j.immuni.2011.08.008; PMID: 21867928
   PubMed Web of Science ®Google Scholar
• Piva L, Tetlak P, Claser C, Karjalainen K, Renia L, Ruedl C. Cutting edge: Clec9A+ dendritic cells mediate the development of experimental cerebral malaria. J Immunol 2012; 189:1128 - 32; http://dx.doi.org/10.4049/jimmunol.1201171; PMID: 22732587
   PubMed Web of Science ®Google Scholar
• Edelson BT, Wumesh KC, Juang R, Kohyama M, Benoit LA, Klekotka PA, et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J Exp Med 2010; 207:823 - 36; http://dx.doi.org/10.1084/jem.20091627; PMID: 20351058
   PubMed Web of Science ®Google Scholar
• Crozat K, Tamoutounour S, Vu Manh TP, Fossum E, Luche H, Ardouin L, et al. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type. J Immunol 2011; 187:4411 - 5; http://dx.doi.org/10.4049/jimmunol.1101717; PMID: 21948982
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Liu K, Helft J, Bogunovic M, Greter M, Hashimoto D, et al. The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med 2009; 206:3115 - 30; http://dx.doi.org/10.1084/jem.20091756; PMID: 20008528
   PubMed Web of Science ®Google Scholar
• Edelson BT, Bradstreet TR, Kc W, Hildner K, Herzog JW, Sim J, et al. Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization. PLoS ONE 2011; 6:e25660; http://dx.doi.org/10.1371/journal.pone.0025660; PMID: 22065991
   PubMed Web of Science ®Google Scholar
• Tussiwand R, Lee WL, Murphy TL, Mashayekhi M, Kc W, Albring JC, et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 2012; http://dx.doi.org/10.1038/nature11531; PMID: 22992524
   PubMed Web of Science ®Google Scholar
• Bachem A, Güttler S, Hartung E, Ebstein F, Schaefer M, Tannert A, et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 2010; 207:1273 - 81; http://dx.doi.org/10.1084/jem.20100348; PMID: 20479115
   PubMed Web of Science ®Google Scholar
• Crozat K, Guiton R, Contreras V, Feuillet V, Dutertre CA, Ventre E, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 2010; 207:1283 - 92; http://dx.doi.org/10.1084/jem.20100223; PMID: 20479118
   PubMed Web of Science ®Google Scholar
• Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010; 207:1247 - 60; http://dx.doi.org/10.1084/jem.20092140; PMID: 20479116
   PubMed Web of Science ®Google Scholar
• Poulin LF, Salio M, Griessinger E, Anjos-Afonso F, Craciun L, Chen JL, et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med 2010; 207:1261 - 71; http://dx.doi.org/10.1084/jem.20092618; PMID: 20479117
   PubMed Web of Science ®Google Scholar
• Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, et al. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med 2010; 207:2703 - 17; http://dx.doi.org/10.1084/jem.20092720; PMID: 20975040
   PubMed Web of Science ®Google Scholar
• Ahrens S, Zelenay S, Sancho D, Hanč P, Kjær S, Feest C, et al. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012; 36:635 - 45; http://dx.doi.org/10.1016/j.immuni.2012.03.008; PMID: 22483800
   PubMed Web of Science ®Google Scholar
• Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P, et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009; 458:899 - 903; http://dx.doi.org/10.1038/nature07750; PMID: 19219027
   PubMed Web of Science ®Google Scholar
• Zhang JG, Czabotar PE, Policheni AN, Caminschi I, Wan SS, Kitsoulis S, et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012; 36:646 - 57; http://dx.doi.org/10.1016/j.immuni.2012.03.009; PMID: 22483802
   PubMed Web of Science ®Google Scholar
• Dorner BG, Dorner MB, Zhou X, Opitz C, Mora A, Güttler S, et al. Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity 2009; 31:823 - 33; http://dx.doi.org/10.1016/j.immuni.2009.08.027; PMID: 19913446
   PubMed Web of Science ®Google Scholar
• Galibert L, Diemer GS, Liu Z, Johnson RS, Smith JL, Walzer T, et al. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J Biol Chem 2005; 280:21955 - 64; http://dx.doi.org/10.1074/jbc.M502095200; PMID: 15781451
   PubMed Web of Science ®Google Scholar
• Bachem A, Hartung E, Güttler S, Mora A, Zhou X, Hegemann A, et al. Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-Presentation. Front Immunol 2012; 3:214; http://dx.doi.org/10.3389/fimmu.2012.00214; PMID: 22826713
   PubMed Web of Science ®Google Scholar
• Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JC, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008; 112:3264 - 73; http://dx.doi.org/10.1182/blood-2008-05-155176; PMID: 18669894
   PubMed Web of Science ®Google Scholar
• Huysamen C, Willment JA, Dennehy KM, Brown GD. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J Biol Chem 2008; 283:16693 - 701; http://dx.doi.org/10.1074/jbc.M709923200; PMID: 18408006
   PubMed Web of Science ®Google Scholar
• Poulin LF, Reyal Y, Uronen-Hansson H, Schraml BU, Sancho D, Murphy KM, et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood 2012; 119:6052 - 62; http://dx.doi.org/10.1182/blood-2012-01-406967; PMID: 22442345
   PubMed Web of Science ®Google Scholar
• Sancho D, Mourão-Sá D, Joffre OP, Schulz O, Rogers NC, Pennington DJ, et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 2008; 118:2098 - 110; http://dx.doi.org/10.1172/JCI34584; PMID: 18497879
   PubMed Web of Science ®Google Scholar
• Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 2012; 37:60 - 73; http://dx.doi.org/10.1016/j.immuni.2012.04.012; PMID: 22795876
   PubMed Web of Science ®Google Scholar
• Mittag D, Proietto AI, Loudovaris T, Mannering SI, Vremec D, Shortman K, et al. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J Immunol 2011; 186:6207 - 17; http://dx.doi.org/10.4049/jimmunol.1002632; PMID: 21515786
   PubMed Web of Science ®Google Scholar
• Lesterhuis WJ, Aarntzen EH, De Vries IJ, Schuurhuis DH, Figdor CG, Adema GJ, et al. Dendritic cell vaccines in melanoma: from promise to proof?. Crit Rev Oncol Hematol 2008; 66:118 - 34; http://dx.doi.org/10.1016/j.critrevonc.2007.12.007; PMID: 18262431
   PubMed Web of Science ®Google Scholar
• Vulink A, Radford KJ, Melief C, Hart DN. Dendritic cells in cancer immunotherapy. Adv Cancer Res 2008; 99:363 - 407; http://dx.doi.org/10.1016/S0065-230X(07)99006-5; PMID: 18037410
   PubMed Web of Science ®Google Scholar
• Kroczek RA, Henn V. The Role of XCR1 and its Ligand XCL1 in Antigen Cross-Presentation by Murine and Human Dendritic Cells. Front Immunol 2012; 3:14; http://dx.doi.org/10.3389/fimmu.2012.00014; PMID: 22566900
   PubMedGoogle Scholar
• Joffre OP, Sancho D, Zelenay S, Keller AM, Reis e Sousa C. Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A. Eur J Immunol 2010; 40:1255 - 65; http://dx.doi.org/10.1002/eji.201040419; PMID: 20333625
   PubMed Web of Science ®Google Scholar
• Lahoud MH, Ahmet F, Kitsoulis S, Wan SS, Vremec D, Lee CN, et al. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J Immunol 2011; 187:842 - 50; http://dx.doi.org/10.4049/jimmunol.1101176; PMID: 21677141
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Ahlers JD. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?. J Immunol 2009; 183:6883 - 92; http://dx.doi.org/10.4049/jimmunol.0901466; PMID: 19923474
   PubMed Web of Science ®Google Scholar
• Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?. Vaccine 2008; 26:3197 - 208; http://dx.doi.org/10.1016/j.vaccine.2008.03.095; PMID: 18486285
   PubMed Web of Science ®Google Scholar
• Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002; 196:1627 - 38; http://dx.doi.org/10.1084/jem.20021598; PMID: 12486105
   PubMed Web of Science ®Google Scholar
• Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004; 199:815 - 24; http://dx.doi.org/10.1084/jem.20032220; PMID: 15024047
   PubMed Web of Science ®Google Scholar
• Carter RW, Thompson C, Reid DM, Wong SY, Tough DF. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J Immunol 2006; 177:2276 - 84; PMID: 16887988
   PubMed Web of Science ®Google Scholar
• Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007; 315:107 - 11; http://dx.doi.org/10.1126/science.1136080; PMID: 17204652
   PubMed Web of Science ®Google Scholar
• Caminschi I, Vremec D, Ahmet F, Lahoud MH, Villadangos JA, Murphy KM, et al. Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice. Mol Immunol 2012; 50:9 - 17; http://dx.doi.org/10.1016/j.molimm.2011.11.008; PMID: 22209163
   PubMed Web of Science ®Google Scholar
• Tagliani E, Guermonprez P, Sepúlveda J, López-Bravo M, Ardavín C, Amigorena S, et al. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells. J Immunol 2008; 180:3201 - 9; PMID: 18292544
   PubMed Web of Science ®Google Scholar
• Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, et al. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Clin Cancer Res 2009; 15:4612 - 21; http://dx.doi.org/10.1158/1078-0432.CCR-08-3321; PMID: 19584156
   PubMed Web of Science ®Google Scholar
• Lahoud MH, Proietto AI, Ahmet F, Kitsoulis S, Eidsmo L, Wu L, et al. The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J Immunol 2009; 182:7587 - 94; http://dx.doi.org/10.4049/jimmunol.0900464; PMID: 19494282
   PubMed Web of Science ®Google Scholar
• He LZ, Crocker A, Lee J, Mendoza-Ramirez J, Wang XT, Vitale LA, et al. Antigenic targeting of the human mannose receptor induces tumor immunity. J Immunol 2007; 178:6259 - 67; PMID: 17475854
   PubMed Web of Science ®Google Scholar
• Nchinda G, Kuroiwa J, Oks M, Trumpfheller C, Park CG, Huang Y, et al. The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J Clin Invest 2008; 118:1427 - 36; http://dx.doi.org/10.1172/JCI34224; PMID: 18324335
   PubMed Web of Science ®Google Scholar
• Idoyaga J, Lubkin A, Fiorese C, Lahoud MH, Caminschi I, Huang Y, et al. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci USA 2011; 108:2384 - 9; http://dx.doi.org/10.1073/pnas.1019547108; PMID: 21262813
   PubMed Web of Science ®Google Scholar
• den Haan JM, Lehar SM, Bevan MJ. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 2000; 192:1685 - 96; http://dx.doi.org/10.1084/jem.192.12.1685; PMID: 11120766
   PubMed Web of Science ®Google Scholar
• Pooley JL, Heath WR, Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol 2001; 166:5327 - 30; PMID: 11313367
   PubMed Web of Science ®Google Scholar
• Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J, et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 2003; 197:153 - 62; http://dx.doi.org/10.1084/jem.20021109; PMID: 12538655
   PubMed Web of Science ®Google Scholar
• Kamphorst AO, Guermonprez P, Dudziak D, Nussenzweig MC. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J Immunol 2010; 185:3426 - 35; http://dx.doi.org/10.4049/jimmunol.1001205; PMID: 20729332
   PubMed Web of Science ®Google Scholar
• Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440:808 - 12; http://dx.doi.org/10.1038/nature04596; PMID: 16489357
   PubMed Web of Science ®Google Scholar
• Hou B, Reizis B, DeFranco AL. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 2008; 29:272 - 82; http://dx.doi.org/10.1016/j.immuni.2008.05.016; PMID: 18656388
   PubMed Web of Science ®Google Scholar
• Kastenmüller K, Wille-Reece U, Lindsay RW, Trager LR, Darrah PA, Flynn BJ, et al. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest 2011; 121:1782 - 96; http://dx.doi.org/10.1172/JCI45416; PMID: 21540549
   PubMed Web of Science ®Google Scholar
• Spörri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 2005; 6:163 - 70; http://dx.doi.org/10.1038/ni1162; PMID: 15654341
   PubMed Web of Science ®Google Scholar
• Burgdorf S, Schölz C, Kautz A, Tampé R, Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 2008; 9:558 - 66; http://dx.doi.org/10.1038/ni.1601; PMID: 18376402
   PubMed Web of Science ®Google Scholar
• Caskey M, Lefebvre F, Filali-Mouhim A, Cameron MJ, Goulet JP, Haddad EK, et al. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 2011; 208:2357 - 66; http://dx.doi.org/10.1084/jem.20111171; PMID: 22065672
   PubMed Web of Science ®Google Scholar
• Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho T, et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 2003; 33:827 - 33; http://dx.doi.org/10.1002/eji.200323797; PMID: 12672047
   PubMed Web of Science ®Google Scholar
• Kassianos AJ, Hardy MY, Ju X, Vijayan D, Ding Y, Vulink AJ, et al. Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli. Eur J Immunol 2012; 42:1512 - 22; http://dx.doi.org/10.1002/eji.201142098; PMID: 22678905
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov 2012; 11:215 - 33; http://dx.doi.org/10.1038/nrd3626; PMID: 22301798
   PubMed Web of Science ®Google Scholar
• Flynn BJ, Kastenmüller K, Wille-Reece U, Tomaras GD, Alam M, Lindsay RW, et al. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc Natl Acad Sci USA 2011; 108:7131 - 6; http://dx.doi.org/10.1073/pnas.1103869108; PMID: 21467219
   PubMed Web of Science ®Google Scholar
• Trumpfheller C, Longhi MP, Caskey M, Idoyaga J, Bozzacco L, Keler T, et al. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity. J Intern Med 2012; 271:183 - 92; http://dx.doi.org/10.1111/j.1365-2796.2011.02496.x; PMID: 22126373
   PubMed Web of Science ®Google Scholar